919529-35-4

Basic information

• Product Name: D-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-, hydrazide
• CAS NO: 919529-35-4
• Molecular Formula: C14H21N3O3
• Molecular Weight: 279.339
• Mol File: 919529-35-4.mol

Chemical Properties

• CAS DataBase Reference: D-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-, hydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: D-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-, hydrazide(919529-35-4)
• EPA Substance Registry System: D-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-, hydrazide(919529-35-4)

Safety Data

• Hazardous Substances Data: 919529-35-4(Hazardous Substances Data)

Upstream product

• 18942-49-9 Boc-D-Phe-OH 
• 19901-50-9 methyl (2R)-2-(t-butoxycarbonylamino)-3-phenylpropionate 

Downstream Products

• 125511-89-9 methyl (R)-2-((R)-2-((tert-butoxycarbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoate 

Relevant articles and documents

The solid state VCD of a novel N-acylhydrazone trifluoroacetate

A novel N-acylhydrazone with pharmaceutical importance was subject of structural and IR/VCD investigations in the solid state. In the crystal structure, dimers of anion-cation pairs are stabilized by H-bonding and ionic interactions. Some less common inte

HYDRAZIDE CONJUGATES AS IMAGING AGENTS

The present disclosure is directed to diagnostic agents. More specifically, the disclosure is directed to compounds, diagnostic agents, compositions, and kits for detecting and/or imaging and/or monitoring a pathological disorder associated with coronary plaque, carotid plaque, aortic plaque, plaque of the arterial vessel, aneurism, vasculitis, and other diseases of the arterial wall. In addition, the disclosure is directed to methods of detecting and/or imaging and/or monitoring changes in the arterial wall, including expansive and constrictive remodeling, total vessel wall area, internal lumen size, and exterior artery perimeter.